天安新材(603725.SH):擬將244.87萬元節餘募集資金永久補充流動資金
格隆匯 8 月 28日丨天安新材(603725.SH)公告,公司於2020年8月27日召開了第三屆董事會第六次會議、第三屆監事會第六次會議審議通過了《關於首次公開發行股票募投項目結項並將節餘募集資金永久補充流動資金的議案》,公司首次公開發行募投項目已全部建設完畢,同意將上述項目予以結項。本次結項後,公司首次公開發行募投項目已實施完畢。
結合公司自身實際經營情況,為更合理地使用募集資金,提高募集資金使用效率,公司擬將上述募集資金投資項目結項後的節餘募集資金244.87萬元(具體金額以募集資金專户註銷時銀行實際餘額為準)永久補充流動資金,用於公司日常生產經營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.